Ohio’s youngest death row inmate never touched the murder weapon. Why was he sentenced to death?

Franklin Zimring quoted by The Washington Post, Dec. 16, 2016

“It’s crystal clear that the difference between life or death is electing a jury trial, not what happened at the crime scene,” said Zimring, who has written about capital punishment. “The thing that makes that forcefully problematic is that the only difference between life and death is the procedural decision that the defendant made.”

The coat hanger comes of age

Jill Adams quoted by ThinkProgress, Dec. 15, 2016

In a society in which abortion, particularly self-induced abortion, is already stigmatized, Adams worries that the coat hanger “may be perpetuating misconceptions about self-induced abortion in the present day that are harmful…Self-induced abortion in 2016 is happening, for the most part, safely, effectively, and privately.”

What Trump’s energy and environment cabinet picks mean for CA

Daniel Farber quoted by KPCC-FM, Dec. 15, 2016

“California is a biological hot spot in terms of biological diversity. We also have a lot of development pressures, and administration of the Endangered Species Act is really important,” said Dan Farber. … Zinke could instruct the US Fish and Wildlife service’s biologists to favor agricultural and development interests over efforts to protect endangered species, Farber said.

Making strides: Israel studies flourishing at Cal

Kenneth Bamberger quoted by jWeekly.com, Dec. 15, 2016

As Bamberger notes, Cal’s scholarly approach to the study of Israel has mellowed the campus climate by “creating multiple ongoing opportunities for students and faculty to delve deeply into the range of aspects of Israeli society and engage intellectually. That’s what universities do well.”

Lawyers for Virginia death-row inmate sue to stop lethal injection

Jen Moreno quoted by The Washington Post, Dec. 14, 2016

“Virginia’s secrecy law incentivizes the state to use compounded drugs, even when manufactured drugs are available, because the purchase from the compounding pharmacy is made confidential,” Jennifer Moreno of Berkeley Law School’s Lethal Injection Project said in a statement. “Use of compounded drugs gratuitously adds risks of pain and suffering, and buying drugs from a compounding pharmacy is significantly more expensive and thus a questionable use of taxpayer money.”

Cisco v. Aista awaits a jury verdict under the Oracle v. Google shadow

Peter Menell quoted by Ars Technica, Dec. 14, 2016

“In my view, Cisco is seeking to benefit from the Federal Circuit’s misinterpretation of 9th Circuit law regarding APIs,” Menell said in an e-mail exchange with Ars. “By including a patent claim, despite the relatively small magnitude of Cisco’s patent damage request, Cisco ensured that the Federal Circuit, rather than the 9th Circuit, would have appellate jurisdiction over the far more valuable copyright causes of action.”

A potential hitch in Zuckerberg’s stock plan for Facebook

Steven Davidoff Solomon writes for The New York Times, Dec. 13, 2016

To prevent Mr. Zuckerberg from further cementing his grip on Facebook, shareholders have sued in a Delaware court, seeking to block the stock plan. A similar legal effort was tried against Google’s new class of shares, but that lawsuit was settled on terms that I described as providing little benefit to shareholders. This time around, however, the plaintiffs’ lawyers may have hit pay dirt.

How to ensure agencies consider rules’ economic impact

Steven Davidoff Solomon quoted by American Banker, Dec. 13, 2016

After the Business Roundtable decision, Berkeley law professor Steven Davidoff commented disapprovingly. He wrote, “The opinion appears to create an almost insurmountable barrier for the SEC by requiring that it provide empirical support amounting to proof that its rules would be effective.”